ANI Pharmaceuticals (ANIP)
(Real Time Quote from BATS)
$61.78 USD
-0.41 (-0.66%)
Updated Jul 22, 2024 12:34 PM ET
2-Buy of 5 2
B Value A Growth D Momentum A VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/14/24 |
---|---|
Current Quarter | 0.92 |
EPS Last Quarter | 1.21 |
Last EPS Surprise | 23.47% |
ABR | 1.20 |
Earnings ESP
|
-4.35% |
---|---|
Current Year | 4.44 |
Next Year | 5.42 |
EPS (TTM) | 4.76 |
P/E (F1) | 14.02 |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 127.11M | 136.53M | 571.11M | 697.64M |
# of Estimates | 4 | 4 | 2 | 2 |
High Estimate | 128.80M | 140.12M | 575.01M | 708.97M |
Low Estimate | 126.00M | 134.40M | 567.20M | 686.31M |
Year ago Sales | 116.55M | 131.83M | 486.82M | 571.11M |
Year over Year Growth Est. | 9.06% | 3.56% | 17.31% | 22.16% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.92 | 1.09 | 4.44 | 5.42 |
# of Estimates | 4 | 4 | 2 | 2 |
Most Recent Consensus | 0.96 | 1.05 | 4.48 | 5.68 |
High Estimate | 0.98 | 1.14 | 4.48 | 5.68 |
Low Estimate | 0.88 | 1.05 | 4.39 | 5.16 |
Year ago EPS | 1.28 | 1.27 | 4.71 | 4.44 |
Year over Year Growth Est. | -28.13% | -14.17% | -5.73% | 22.18% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 1 | 1 | 2 |
Up Last 60 Days | 0 | 1 | 1 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 1 | 1 | 0 |
Down Last 60 Days | 1 | 1 | 1 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.92 | 1.09 | 4.44 | 5.42 |
7 Days Ago | 0.92 | 1.09 | 4.44 | 5.42 |
30 Days Ago | 0.94 | 1.10 | 4.41 | 4.85 |
60 Days Ago | 0.94 | 1.10 | 4.41 | 4.85 |
90 Days Ago | 1.06 | 1.17 | 4.42 | 4.96 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.88 | 1.06 | 4.44 | 5.42 |
Zacks Consensus Estimate | 0.92 | 1.09 | 4.44 | 5.42 |
Earnings ESP | -4.35% | -2.99% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 1.21 | 1.00 | 1.27 | 1.28 | NA |
Estimate | 0.98 | 0.80 | 0.76 | 0.64 | NA |
Difference | 0.23 | 0.20 | 0.51 | 0.64 | 0.40 |
Surprise | 23.47% | 25.00% | 67.11% | 100.00% | 53.90% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more